HoldsUp

Sara Gottfried

Dr. Sara Gottfried is an author and researcher focused on women's health, functional medicine, and lifestyle interventions. Her published research covers topics including the vaginal microbiome, continuous glucose monitoring for pre-diabetes detection, women's cardiometabolic health, and neuroimaging studies on the effects of meditation practices on brain function and glucose metabolism.

19 claims checked on air: 4 context 2 contradicted 2 overstated 8 supported 3 unverified

What they said on air

0:09:09unverifiedvery lowWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Based on structural brain imaging, sex can be classified as male or female with approximately 85% accuracy.

"if you look at a male versus female brain on imaging, you can tell with about 85% certainty that one is female, one is male." (said at 0:09:09)

No published record matching the specific claim that structural brain imaging allows male versus female classification with approximately 85% accuracy was located; this does not prove the claim false.

0:09:20contradictedhighWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Women tend to have a larger hippocampus up until a certain age, while men tend to have a larger cerebellum.

"in general, we know that women tend to have a bigger hippocampus, at least up until a certain age, and men tend to have a larger cerebellum, which is responsible for movement and coordination and other things." (said at 0:09:20)

The claim that women tend to have a larger hippocampus (up to a certain age) is contradicted by meta-analytic MRI evidence. Meta-analyses of structural brain imaging show that uncorrected absolute hippocampal volume is larger in men across all age groups, primarily reflecting larger overall brain size in males. When adjusted for total brain volume or intracranial volume, there is no statistically significant sex difference in hippocampal volume.

0:10:19unverifiedvery lowWeight Loss and the Brain - with Dr. Sara Gottfried | The E

The rates of depression, insomnia, and Alzheimer's disease are approximately double in women compared to men.

"We know that the rate of depression, the rate of insomnia, the rate of Alzheimer's disease is about double in women compared to men." (said at 0:10:19)

No published record matching the claim that the rates of depression, insomnia, and Alzheimer's disease are approximately double in women compared to men was located; this does not prove the claim false.

0:15:44needs contextmoderateWeight Loss and the Brain - with Dr. Sara Gottfried | The E

On average, men tend to have a larger amygdala than women.

"I think about some of the imaging data again and the differences between the male and the female brain, and I know that on average men tend to have a larger amygdala." (said at 0:15:44)

In absolute (uncorrected) volume, men on average have an amygdala approximately 10% larger than women. However, meta-analytic evidence shows that this difference is fully accounted for by overall differences in total brain volume and intracranial volume (which are roughly 11% to 12% larger in men). When amygdala volume is adjusted or normalized for total brain size, the difference between sexes becomes small (<1% to 2.5%) and statistically non-significant, indicating that the amygdala is not selectively or disproportionately enlarged in men.

0:18:11supportedmoderateWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Perimenopause lasts on average for 2 to 8 years, typically between the ages of 35 and 51.

"she looks at perimenopause, which on average lasts for women for 2 to 8 years, typically between 35 and 51" (said at 0:18:11)

Large prospective cohort data, such as the multiethnic Study of Women's Health Across the Nation (SWAN), show that the menopausal transition (perimenopause) typically lasts around 4 to 8 years on average, with median duration ranging from approximately 4.4 to 8.6 years depending on age of onset. Perimenopause generally starts in a woman's late 30s to 40s (around ages 35–45) and concludes at natural menopause, which occurs at an average age of 51.

0:18:28supportedlowWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Research by Lisa Mosconi shows that women begin developing cerebral glucose hypometabolism in perimenopause, preceding Alzheimer's disease diagnosis by over 25 years.

"And what she's found is that women, starting in perimenopause, have these changes in the brain that predate the diagnosis of Alzheimer's by 25-plus years. Now, much of your work is about, okay, what can we do to prevent that arc to Alzheimer's disease? And what I think is so interesting about her work is that she's seen these changes—I think of it as kind of a slowdown in metabolism of the brain, she calls it cerebral hypometabolism, meaning that glucose just isn't taken up in the same way." (said at 0:18:28)

Neuroimaging research led by Dr. Lisa Mosconi demonstrated that women transitionally develop cerebral glucose hypometabolism in Alzheimer's disease-vulnerable brain regions starting during perimenopause (typically in their 40s and 50s), several decades before the typical age of clinical Alzheimer's disease diagnosis (typically age 75+). Using 18F-FDG-PET scans, these observational studies showed that perimenopausal and postmenopausal women exhibit significant reductions in brain glucose metabolism compared to premenopausal controls and age-matched men.

0:19:35needs contextlowWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Approximately 20% of women in perimenopause show no cerebral metabolic decline on brain imaging, resembling men through the same period.

"And—and what I think is exciting is that she's also found that 20% of women in perimenopause have no change at all. They look more like men who have no change through the same time period." (said at 0:19:35)

Published multimodality brain imaging studies by Dr. Lisa Mosconi and colleagues confirm the speaker's broader point: age-matched men maintain stable cerebral glucose metabolism during midlife, whereas women undergoing the perimenopausal and postmenopausal transitions exhibit significant reductions in brain glucose metabolism (CMRglc) and mitochondrial bioenergetics on FDG-PET imaging compared to premenopausal controls and men. However, peer-reviewed publications from this cohort report group-level declines in metabolic activity (often showing an average 15–25% reduction in brain energy in affected regions), rather than establishing a specific published metric that exactly 20% of perimenopausal women experience zero metabolic change.

0:26:40supportedmoderateWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Women diagnosed with polycystic ovary syndrome (PCOS) exhibit an altered gut microbiome and disrupted gut-brain axis compared to healthy controls.

"We know that women with PCOS have an altered microbiome. We know that gut-brain axis is not normal." (said at 0:26:40)

Multiple systematic reviews and meta-analyses of human observational studies demonstrate that women diagnosed with polycystic ovary syndrome (PCOS) exhibit significant gut microbial dysbiosis compared to healthy controls, characterized by reduced alpha diversity (e.g., lower Chao and Shannon indices) and alterations in relative bacterial abundances (PMID: 37739322, PMID: 37559119). Human clinical case-control studies and systematic reviews also confirm dysregulation of gut-brain axis mediators, including significantly lower serum levels of gut-brain signaling peptides such as ghrelin and serotonin, as well as altered gut microbiome-mediated neuroendocrine pathways (PMID: 42076786, PMID: 40967455).

0:26:44supportedmoderateWeight Loss and the Brain - with Dr. Sara Gottfried | The E

An October 2018 study from the University of Texas demonstrated that individuals in midlife (in their 40s) in the top third of cortisol levels have brain shrinkage along with reduced memory and visual perception.

"She shared with me some data from October 2018 from the University of Texas. I'm sure you probably saw this data too, showing that in midlife, starting in your 40s in both men and women, stress has major effects on brain structure and function. So we know that women are more vulnerable than men. We know that high levels of stress, so if you take the people who have kind of the top third in terms of cortisol, the main hormone of stress, they have shrinkage of the brain. And I haven't seen a lot of data on that in women in their 40s. So I think this is really important. So it affects the structure of the brain, it reduces the volume of the brain, and it also is associated with reduced memory and visual perception." (said at 0:26:44)

A cross-sectional analysis from the Framingham Heart Study led by researchers at the University of Texas Health Science Center at San Antonio (published in Neurology in October 2018) examined 2,231 dementia-free participants with a mean age of 48.5 years. The authors found that individuals in the highest tertile of fasting morning cortisol had significantly lower total cerebral brain volume, reduced frontal and occipital gray matter volumes, and poorer performance on tests of memory and visual perception compared to those in the middle tertile. Furthermore, the inverse association between cortisol and total brain volume was statistically significant in women but not in men.

0:27:53overstatedlowWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Chronic high stress causes telomere shortening, accelerates aging, impairs gut barrier integrity, and contributes to 90% or more of disease.

"We know it shrinks the telomeres. We know it accelerates the aging process. We know it either causes or exacerbates 90% of disease, if not more. We know it pokes holes in the gut lining." (said at 0:27:53)

The speaker's claims bundle established biological associations with substantial hyperbole: 1. **Telomere shortening and aging**: Systematic reviews and meta-analyses show that chronic psychological and social stress is associated with shorter leukocyte telomere length, a cellular marker of biological aging, though meta-analytic effect sizes are very small (e.g., r = -0.06) and subject to potential publication bias. 2. **Gut barrier integrity**: Preclinical and animal models demonstrate that stress increases intestinal permeability (often via mast-cell activation and tight-junction disruption), but human evidence in healthy populations remains mixed and less definitive. 3. **Contributing to 90% or more of disease**: The assertion that stress "either causes or exacerbates 90% of disease, if not more" is an oft-repeated lay statistic without rigorous epidemiological or empirical verification. While chronic stress is a well-established risk factor for cardiovascular, metabolic, mental health, and autoimmune conditions, quantifying it as responsible for ≥90% of all disease is unsupported.

0:32:34needs contextlowWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Only about 3% of the population does well with less than seven hours of sleep per night.

"And we also know that only about 3% of the population does well with less than seven hours of sleep." (said at 0:32:34)

Sleep medicine guidelines and epidemiological studies generally recommend at least 7 hours of sleep per night for adults, noting that genuine "natural short sleepers"—individuals who thrive, maintain normal cognitive function, and experience minimal daytime impairment on less than 7 hours of sleep without accumulating sleep debt—represent a rare segment of the general population (often estimated at around 1% to 3%). However, precise population prevalence estimates remain challenging to verify because rare Mendelian genetic variants associated with familial natural short sleep (such as mutations in BHLHE41/DEC2, ADRB1, NPSR1, and GRM1) are extremely rare and show variable penetrance in large population biobanks. Furthermore, objective laboratory studies indicate that many individuals who subjectively believe they function well on short sleep demonstrate measurable objective drowsiness and microsleeps under low-stimulation conditions.

0:36:15supportedmoderateWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Gut bacterial beta-glucuronidase deconjugates estrogen metabolites, and gut dysbiosis can cause estrogen recirculation and elevated estradiol levels.

"We know that women tend to modulate estrogen levels differently than men, and much of that is governed by a certain set of bacteria. And what we're talking about here is an enzyme called beta-glucuronidase. And so the idea with estrogen as the master regulator in the female body is that you want to produce it, you want to use it, and then you want to get rid of it. You don't want it recirculating in the body over and over again like bad karma. And if you have kind of the dysbiosis, the wrong balance of microbes in your gut, you're more likely to keep recycling it and for your estradiol levels to climb, to get too high." (said at 0:36:15)

Published literature supports the role of the gut microbiome—specifically the 'estrobolome'—in estrogen metabolism and recirculation. Estrogens are conjugated in the liver (e.g., glucuronidation) and excreted via bile into the gastrointestinal tract. Bacterial enzymes, predominantly microbial β-glucuronidases (and sulfatases), deconjugate these metabolites back into free estrogens, permitting their reabsorption across the gut mucosa into the enterohepatic circulation. Alterations or shifts in the composition and enzymatic activity of the gut microbiota can increase deconjugation and reabsorption, raising systemic free estradiol levels.

0:38:10unverifiedvery lowWeight Loss and the Brain - with Dr. Sara Gottfried | The E

After age 35, approximately 70% to 80% of women begin to experience wild fluctuations in estradiol production.

"And so after 35, somewhere around 70 to 80% of women start to fluctuate wildly in how much estradiol they're making, and progesterone changes as well." (said at 0:38:10)

No published record matching the claim that 70% to 80% of women begin experiencing wild fluctuations in estradiol production after age 35 was located; this does not prove the claim false. Standard reproductive aging models and longitudinal endocrine cohorts generally indicate that wide fluctuations in estradiol production are characteristic of the menopausal transition, which typically begins in the mid-to-late 40s rather than the mid-30s.

0:39:35supportedvery lowWeight Loss and the Brain - with Dr. Sara Gottfried | The E

The estrogen 4-quinone metabolic pathway is genotoxic and causes mutations and DNA damage.

"And there's even a 4-quinone pathway that is especially genotoxic, so it can cause mutations and damage to DNA." (said at 0:39:35)

Preclinical in vitro and animal studies demonstrate that metabolism of estrogens via 4-hydroxylation leads to the formation of catechol estrogen-3,4-quinones (CE-3,4-Q). These electrophilic metabolites covalently react with DNA purine bases, primarily forming depurinating adducts (4-OHE1/E2-1-N3Ade and 4-OHE1/E2-1-N7Gua). The resulting apurinic sites and redox-cycling reactive oxygen species cause DNA strand breaks, base damage, and error-prone repair mutations.

0:40:45needs contextmoderateWeight Loss and the Brain - with Dr. Sara Gottfried | The E

The average American woman consumes only about 12 grams of dietary fiber per day.

"and it's sad to me to realize that on average an American woman gets about 12 grams of fiber a day." (said at 0:40:45)

The speaker is correct that American women consume substantially less dietary fiber than recommended (the adequate intake is 25–28 g/day), but the actual national average is slightly higher than 12 grams per day. Nationally representative data from the National Health and Nutrition Examination Survey (NHANES) report average daily fiber intakes among adult U.S. women between roughly 14.8 g/day and 15.4 g/day (for example, 15.4 g/day in women aged 19–50 and 14.8 g/day in postmenopausal women), with subgroups such as non-Hispanic Black women averaging closer to 12–13 g/day.

0:43:35supportedlowWeight Loss and the Brain - with Dr. Sara Gottfried | The E

80% of Americans eat food in their car.

"I was horrified to read this statistic that 80% of Americans eat in their car." (said at 0:43:35)

Published sociological research on mobile eating patterns reports that over 80% of North Americans regularly eat in their cars, aligning with the cited statistic.

0:44:10supportedmoderateWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Perceptions of social isolation, rejection, or conflict trigger the immune system to ramp up inflammation even in the absence of actual physical injury.

"what happens with the way our DNA evolved is that if you have this perception of social isolation, social rejection, or social conflict, it cues the immune system to prepare for physical injury, meaning that it ramps up and becomes inflamed even in the absence of any sort of physical injury actually occurring." (said at 0:44:10)

Published research in human social genomics confirms that perceived social isolation, rejection, and social threat activate a conserved transcriptional response to adversity (CTRA) in leukocytes. This pattern involves the up-regulation of pro-inflammatory gene expression and the down-regulation of type I interferon and antibody-related genes via sympathetic nervous system signaling, even without physical injury or acute microbial infection. Evolutionary models and empirical human and non-human primate studies demonstrate that the nervous system interprets social threat as a cue to bias immune transcription toward wound healing and antibacterial inflammatory pathways.

0:47:12overstatedmoderateWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Approximately 6,000 genes are involved in regulating blood sugar.

"There's 6,000 genes for blood sugar, there's many genes involved in height." (said at 0:47:12)

While glycemic regulation and polygenic metabolic traits involve a distributed, polygenic architecture across hundreds of loci throughout the genome, stating that there are specifically "6,000 genes for blood sugar" is an overstatement and does not align with established genomic evidence. Large-scale genome-wide association study (GWAS) meta-analyses—such as those by the MAGIC consortium involving up to hundreds of thousands of participants—identify hundreds of genomic loci and candidate genes (e.g., 242 loci for glycemic traits, 120 loci for random glucose) influencing blood glucose regulation, not 6,000 specific genes.

0:47:40contradictedhighWeight Loss and the Brain - with Dr. Sara Gottfried | The E

Only about 10% to 15% of the risk for chronic disease is genetic, while 85% to 90% is determined by environmental and lifestyle factors.

"And when it comes to something like Alzheimer's disease, or if you look at chronic disease in general, only about 10 to 15% of your risk of chronic disease is related to your genes. The rest, which is what we have a fair amount of control over, the 85 to 90%, is your environment, much of which is determined by your lifestyle choices, how you architect your day." (said at 0:47:40)

The claim that genetic factors account for only 10% to 15% of the risk of chronic diseases such as Alzheimer's disease is contradicted by genetic epidemiological evidence. In the largest population-based twin studies, the heritability of late-onset Alzheimer's disease is estimated to be between 58% and 79%, with non-shared environmental factors explaining the remainder. While environmental and lifestyle factors play important, modifiable roles in chronic disease progression and risk reduction, genetic liability accounts for a substantially larger proportion of disease risk than 10% to 15% across many major chronic conditions, particularly Alzheimer's disease.

Fact-checked episodes

Publications